Gastroenterology & GI Surgery

Welcome to the Mayo Clinic Gastroenterology & GI Surgery Page! With one of the largest group of digestive disease specialists in the world, Mayo Clinic has been recognized as the nation's best Gastroenterology & GI Surgery hospital by U.S. News & World Report. Follow the page to learn about clinical trials and up-to-date research, and find resources for all your gastroenterology needs. Our goal is to connect you to others, and become informed decision makers; so post a comment, share your story, own your health.

Dec 20, 2019

Duration of Crohn’s Disease & Response to Vedolizumab (Entyvio)

By Kanaaz Pereira, Connect Moderator, @kanaazpereira

For patients diagnosed with Crohn’s disease (CD), there seems to be an opportune window in which early intervention may improve outcomes of the disease. Dr. Edward Loftus explains details of a multicenter collaborative  study which found that patients with CD, for 2 years or less,  are more likely to achieve a complete response to vedolizumab (Entyvio), than patients with longer disease duration.

Researchers considered several factors to evaluate the relation between disease duration and vedolizumab effectiveness –

  • Clinical remission, defined as absence of symptoms.
  • Corticosteroid-free remission (CSFR), defined as tapering off steroids completely, achieving clinical remission, and no repeat steroid prescription within 4 weeks of tapering.
  • Endoscopic remission, defined as the absence of ulcers and/or erosions in CD.

What are the implications for patient care?

The findings of the study suggest that patients who’ve been diagnosed with Crohn’s disease should begin treatment with an anti-TNF agent or vedolizumab as soon as possible.

Meet other people, talking about Crohn’s disease, on Mayo Clinic Connect – join the conversation, share experiences, ask questions, and discover your support network. Here are some discussions you might like to follow...



Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Gastroenterology & GI Surgery page.

Please login or register to send an invite.